Mead Johnson Nutrition Company (MJN) - FREE Research Report

Golsby Stephen W who is Director at Mead Johnson Nutrition Company sold 10,000 shares at $83.12 on Jan. 15, 2014. Following this transaction, the Director owned 90,920 shares meaning that the stake was reduced by 9.91% with the 10,000-share transaction.

The shares most recently traded at $83.99, up $0.87, or 1.03% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition Company go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 10,500
  • 24-Week # shares sold: 50,525

The average volume for Mead Johnson Nutrition Company has been 1.5 million shares per day over the past 30 days. Mead Johnson Nutrition Company has a market cap of $17.0 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 0.32% year-to-date as of the close of trading on Wednesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.62%. The company has a P/E ratio of 27.1. Currently there are 5 analysts that rate Mead Johnson Nutrition Company a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Mead Johnson Nutrition Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Get Ready For a Flood of Earnings, and the Healthcare Bill: Week Ahead

5 Cheap Value Stocks That Are Worth a Look Now

Play Smart with FactSet Research

Renault Transports Solid First-Quarter Sales